AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: A retrospective study

The Lancet HIV

Volumn 2, Issue 3, 2015, Pages e92-e97

  Lima, Viviane D ^a,b   Lourenço, Lillian ^a   Yip, Benita ^a   Hogg, Robert S ^a,c   Phillips, Peter ^a,b   Montaner, Julio S G ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANADA; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS JIROVECI; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW; TUBERCULOSIS; WASTING SYNDROME; ACQUIRED IMMUNODEFICIENCY SYNDROME; BRITISH COLUMBIA; HIV INFECTIONS; MIDDLE AGED; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; BRITISH COLUMBIA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84925424231     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00017-X     Document Type: Article

References (35)

1. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA 1996, 276:146-154.
2. Lima VD, Le A, Nosyk B, et al. Development and validation of a composite programmatic assessment tool for HIV therapy. PLoS One 2012, 7:e47859.
3. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012, 308:387-402.
4. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013, 8:e81355.
5. Global report: UNAIDS report on the global AIDS epidemic 2013 [Online] 2013, Joint United Nations Programme on HIV/AIDS (UNAIDS), UNAIDS, Geneva, (accessed Jan 14, 2015). http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
6. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis 2014, 14:281-290.
7. Montaner JS, Lima VD, Harrigan PR, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting. PLoS One 2014, 9:e87872.
8. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013, 339:966-971.
9. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
10. Deeks SG, Lewin SR, Havlir DV The end of AIDS: HIV infection as a chronic disease. Lancet 2013, 382:1525-1533.
11. Havlir D, Beyrer C The beginning of the end of AIDS?. N Engle J Med 2012, 367:685-687.
12. The beginning of the end of AIDS?. Lancet 2012, 380:1967. The Lancet.
13. The beginning of the end? Tracking global commitments on AIDS ONE, (accessed Jan 14, 2015). http://www.one.org/international/policy/the-beginning-of-the-end-the-2013-one-aids-report/?source=blogUSDC102611262013.
14. HIV in British Columbia: annual surveillance report 2012 British Columbia Centre for Disease Control (BCCDC), (accessed Oct 29, 2014). http://www.bccdc.ca/util/about/annreport/default.htm.
15. Lourenco L, Lima VD, Heath K, et al. Process monitoring of an HIV treatment as prevention program in British Columbia, Canada. J Acquir Immune Defic Syndr 2014, 67:e94-109.
16. Schneider E, Whitmore S, Glynn KM, et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm Rep 2008, 57:1-12.
17. Cameron AC, Trivedi PK Regression analysis of count data 1998, Cambridge University Press, Cambridge, UK.
18. Cameron AC, Trivedi PK Microeconometrics: methods and applications 2005, Cambridge University Press, Cambridge, UK.
19. Wood SN Generalized additive models. an introduction with R 2006, Chapman & Hall/CRC, US.
20. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 2000, 283:381-390.
21. El-Sadr WM, Lundgren J, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006, 355:2283-2296. Strategies for Management of Antiretroviral Therapy (SMART) Study Group.
22. Panel on antiretroviral guidelines for adults and adolescents: guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents Department of Health and Human Services (DHHS), (accessed Sept 1, 2014). http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf.
23. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach WHO, (accessed Sept 1, 2014). http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf.
24. Buchacz K, Baker RK, Palella FJ, et al. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS 2010, 24:1549-1559.
25. Cobucci RN, Lima PH, de Souza PC, et al. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. J Infect Public Health 2014, 8:1-10.
26. Fenner L, Reid SE, Fox MP, et al. Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa. Trop Med Int Health 2013, 18:194-198.
27. Schwarcz L, Chen MJ, Vittinghoff E, Hsu L, Schwarcz S Declining incidence f AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance. AIDS 2013, 27:597-605.
28. Grinsztejn B, Luz PM, Pacheco AG, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One 2013, 8:e59768.
29. Jones A, Cremin I, Abdullah F, et al. Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet 2014, 384:272-279.
30. Nosyk B, Montaner JS, Colley G, et al. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis 2014, 14:40-49.
31. Fast track: Ending the AIDS epidemic by 2030 Joint United Nations Programme on HIV/AIDS (UNAIDS), (accessed Sept 1, 2014). http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/20140925_Fast_Track_Brochure.pdf.
32. Fast-track-ending the AIDS epidemic by 2030 Joint United Nations Programme on HIV/AIDS (UNAIDS), (accessed Sept 1, 2014). http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf.
33. The end of AIDS is within our grasp San Francisco AIDS Foundation, (accessed Sept 1, 2014). http://sfaf.org/hiv-info/hot-topics/from-the-experts/end-of-aids-is-within-our-grasp.html.
34. The 20th international AIDS conference: is the end in sight? The Economist, (accessed Sept 1, 2014). http://www.economist.com/node/21608568/print.
35. Dowdle WR The principles of disease elimination and eradication. MMWR 1999, 48(SU01):23-27.